Anti-cancer properties of quercetin in osteosarcoma

Parisa Maleki Dana1, Fatemeh Sadoughi1, Zatollah Asemi2

  • 1Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, I.R. of Iran.

Insights

Quercetin shows potential as an anti-cancer agent for osteosarcoma, a rare bone cancer in children. This review explores its effects on cancer cell proliferation, apoptosis, invasion, and chemo-resistance.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Osteosarcoma is the most common primary bone tumor in children, with historically unfavorable treatment outcomes.
  • Current osteosarcoma treatments lack targeted therapies, necessitating research into novel therapeutic agents.
  • Quercetin, a plant-derived flavonoid, exhibits known anti-cancer properties across various human cancer types.

Purpose of the Study:

  • To review existing research on the antitumor effects of quercetin in osteosarcoma.
  • To investigate quercetin's mechanisms of action against osteosarcoma cells.
  • To evaluate quercetin's potential as a targeted therapy for osteosarcoma.

Main Methods:

  • Literature review of studies investigating quercetin's role in osteosarcoma.
  • Analysis of quercetin's impact on osteosarcoma cell proliferation and apoptosis.
  • Examination of quercetin's effects on invasion and chemo-resistance in osteosarcoma models.

Main Results:

  • Quercetin demonstrates the ability to inhibit osteosarcoma cell proliferation.
  • The compound influences apoptosis pathways in osteosarcoma cells.
  • Quercetin may modulate protein expression and signaling pathways involved in invasion and chemo-resistance.

Conclusions:

  • Quercetin exhibits promising antitumor activities against osteosarcoma.
  • Further research into quercetin's therapeutic potential for osteosarcoma is warranted.
  • Quercetin could offer a novel therapeutic strategy for osteosarcoma treatment.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K